John R. Boot
Eli Lilly (United Kingdom) · 30 works · 611 citations · h-index 16
Top works
- Human autoantibodies specific for the α 1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons
- Mass spectral characterization of 6-oxo-PGF1α
- The identification of two novel prostaglandins and a thromboxane
- The Role of Autoantibodies in Lambert‐Eaton Myasthenic Syndromeaa
- In vitro modulation of the eosinophil‐dependent enhancement of the permeability of the bronchial mucosa
- 1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors
- Discovery and structure–activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors
- The comparative in vitro pharmacology of leukotriene D4 and its isomers
- Synthesis of 8,9-leukotriene C3 and D3
- Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression
- γ-Hexachlorocyclohexane stimulation of macrophage phospholipid hydrolysis and leukotriene production
- Differential effects of ω-conotoxin GVIA and MVIIC on nerve stimulation induced contractions of guinea-pig ileum and rat vas deferens
- Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa
- Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter
- PSAB-OFP, a selective α7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor
- The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig
- High affinity ligands for the α7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor
- SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis
- Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives
- In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties